Cash flow Mithra Pharmaceuticals S.A.

Equities

MITRA

BE0974283153

Pharmaceuticals

Market Closed - Euronext Bruxelles Other stock markets 11:35:26 2024-04-26 am EDT			5-day change	1st Jan Change
0.2160 ^EUR	-1.82%		-.--%	-82.78%

Jun. 11	Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. acquired Neuralis and Estetra from Mithra Pharmaceuticals SA.	CI
May. 28	Mithra Delays AGM Amid Monetization Process	MT

841af8f509e265938f05ce45.9x8LR_YlvbRDnsjlRlZmQQGiZQvBrMvhSIe4DUobad8.xGZfN69G0NMG-6ypFzwTJ0-aN1H0naGCKfPOWyNNOIvDRnwKskHl9jXJhQ

Published financial data: MITHRA PHARMACEUTICALS S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2018	2019	2020	2021	2022
Revenues	57.88M	96.52M	9.03M	22.67M	67M
Total Revenues	57.88M	96.52M	9.03M	22.67M	67M
Cost of Goods Sold, Total	1.57M	2.49M	3.46M	15.72M	19.62M
Gross Profit	56.3M	94.03M	5.57M	6.94M	47.37M
Selling General & Admin Expenses, Total	10.96M	16.31M	17.37M	14.39M	16.78M
R&D Expenses	35.71M	57.07M	78.46M	85.24M	64.04M
Other Operating Expenses	-4.55M	-5.4M	-6.57M	-4.81M	-7.2M
Other Operating Expenses, Total	42.12M	67.98M	89.25M	94.82M	73.62M
Operating Income	14.19M	26.05M	-83.68M	-87.88M	-26.25M
Interest Expense, Total	-5.36M	-3.32M	-3.5M	-11.76M	-17M
Interest And Investment Income	-	-	-	-	2.97M
Net Interest Expenses	-5.36M	-3.32M	-3.5M	-11.76M	-14.03M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-	-	542K	-341K	-5.68M
Other Non Operating Income (Expenses)	236K	-3.11M	-1.24M	1.46M	3.65M
EBT, Excl. Unusual Items	9.06M	19.62M	-87.88M	-98.52M	-42.3M
Gain (Loss) On Sale Of Investments	-	2.76M	-4.92M	-5.98M	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Other Unusual Items	-46.55M	-54.73M	-18.11M	-19.26M	30.82M
EBT, Incl. Unusual Items	-37.49M	-32.35M	-111M	-124M	-11.48M
Income Tax Expense	-9.88M	-5.13M	-18.84M	-6.9M	48.14M
Earnings From Continuing Operations	-27.61M	-27.22M	-92.09M	-117M	-59.62M
Earnings Of Discontinued Operations	15.24M	658K	-	-	-
Net Income to Company	-12.36M	-26.56M	-92.09M	-117M	-59.62M
Net Income - (IS)	-12.36M	-26.56M	-92.09M	-117M	-59.62M
Net Income to Common Incl Extra Items	-12.36M	-26.56M	-92.09M	-117M	-59.62M
Net Income to Common Excl. Extra Items	-27.61M	-27.22M	-92.09M	-117M	-59.62M
Per Share Items
Net EPS - Basic	-0.34	-0.7	-2.25	-2.69	-1.22
Basic EPS - Continuing Operations	-0.75	-0.72	-2.25	-2.69	-1.22
Basic Weighted Average Shares Outstanding	36.56M	37.75M	40.99M	43.43M	49.06M
Net EPS - Diluted	-0.34	-0.7	-2.25	-2.69	-1.22
Diluted EPS - Continuing Operations	-0.75	-0.72	-2.25	-2.69	-1.22
Diluted Weighted Average Shares Outstanding	36.56M	37.75M	40.99M	43.43M	49.06M
Normalized Basic EPS	0.15	0.32	-1.34	-1.42	-0.54
Normalized Diluted EPS	0.15	0.32	-1.34	-1.42	-0.54
Dividend Per Share	-	-	-	-	-
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	17.04M	28.47M	-77.94M	-82.99M	-20.62M
EBITA	13.42M	26.18M	-80.13M	-86.3M	-24.45M
EBIT	14.19M	26.05M	-83.68M	-87.88M	-26.25M
EBITDAR	17.43M	28.52M	-77.85M	-82.67M	-20.42M
Effective Tax Rate - (Ratio)	26.37	15.85	16.98	5.57	-419.29
Total Current Taxes	355K	581K	36K	316K	94K
Total Deferred Taxes	-4.22M	-5.44M	-18.87M	-7.21M	48.04M
Normalized Net Income	5.66M	12.26M	-54.93M	-61.58M	-26.44M
Interest on Long-Term Debt	-	3.06M	2.24M	2.17M	2.35M
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.98M	1.54M	1.43M	1.87M	2.1M
General and Administrative Expenses	8.98M	14.77M	15.93M	12.52M	14.68M
Research And Development Expense From Footnotes	35.71M	57.07M	78.46M	85.24M	64.04M
Net Rental Expense, Total	391K	49K	83K	322K	198K
Imputed Operating Lease Interest Expense	110K	6.76K	8.83K	88.84K	79K
Imputed Operating Lease Depreciation	281K	42.24K	74.17K	233K	119K
Maintenance & Repair Expenses, Total	-	-	-	1.51M	1.2M
Stock-Based Comp., Other (Total)	1.18M	4.9M	7.27M	1.06M	1.98M
Total Stock-Based Compensation	1.18M	4.9M	7.27M	1.06M	1.98M

Fiscal Period: December	2018	2019	2020	2021	2022
Assets
Cash And Equivalents	119M	49.72M	139M	32.87M	28.28M
Short Term Investments	-	46K	14K	-	-
Total Cash And Short Term Investments	119M	49.77M	139M	32.87M	28.28M
Accounts Receivable, Total	19.54M	22.43M	56.76M	17.16M	54.84M
Other Receivables	2.72M	2.05M	2.39M	1.68M	6.89M
Total Receivables	22.26M	24.48M	59.15M	18.84M	61.73M
Inventory	10.94M	16.23M	35.38M	43.85M	50.31M
Prepaid Expenses	1K	-	1.57M	2.31M	4.67M
Other Current Assets, Total	1.51M	1.05M	3.69M	1.51M	867K
Total Current Assets	154M	91.52M	238M	99.39M	146M
Gross Property Plant And Equipment	90.01M	105M	116M	132M	139M
Accumulated Depreciation	-5.62M	-10.6M	-16.58M	-24.14M	-32.93M
Net Property Plant And Equipment	84.4M	94.04M	99.49M	108M	106M
Long-term Investments	-	22.86M	18.09M	31.9M	21.44M
Goodwill	5.23M	5.23M	5.23M	5.23M	5.23M
Other Intangibles, Total	78.8M	80.05M	76.97M	85.04M	82.94M
Accounts Receivable Long-Term	-	48.98M	200K	49K	2.83M
Deferred Tax Assets Long-Term	27.04M	34.43M	50.9M	63.46M	16.35M
Deferred Charges Long-Term	3.1M	7.44M	12.04M	19.92M	51.97M
Other Long-Term Assets, Total	3.44M	13.1M	20.58M	9.26M	9.54M
Total Assets	356M	398M	522M	422M	442M
Liabilities
Accounts Payable, Total	13.07M	19.45M	23.32M	16.92M	31.72M
Accrued Expenses, Total	482K	1.32M	2.02M	1.85M	7.36M
Short-term Borrowings	9.75M	5.08M	4M	4M	6M
Current Portion of Long-Term Debt	8.36M	8.86M	32.16M	60.01M	58.61M
Current Portion of Leases	2.14M	6.75M	7.32M	6.56M	5.18M
Current Income Taxes Payable	334K	-	-	-	-
Unearned Revenue Current, Total	868K	-	-	-	-
Other Current Liabilities	1.07M	6.34M	1.93M	6.45M	21.56M
Total Current Liabilities	36.08M	47.8M	70.75M	95.79M	130M
Long-Term Debt	118M	132M	241M	241M	220M
Long-Term Leases	48.01M	45.73M	44.28M	42.35M	38.25M
Unearned Revenue Non Current	-	4.06M	3.71M	-	-
Deferred Tax Liability Non Current	2.2M	4.15M	4.36M	6.09M	4.42M
Other Non Current Liabilities	266K	606K	267K	3.16M	15.52M
Total Liabilities	205M	234M	364M	388M	409M
Common Stock, Total	26.92M	28.02M	31.27M	32.25M	41.23M
Additional Paid In Capital	222M	260M	333M	341M	409M
Retained Earnings	-101M	-128M	-220M	-337M	-396M
Comprehensive Income and Other	3.49M	3.42M	13.69M	-2.55M	-19.93M
Total Common Equity	151M	163M	158M	33.84M	33.69M
Total Equity	151M	163M	158M	33.84M	33.69M
Total Liabilities And Equity	356M	398M	522M	422M	442M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	37.64M	39.13M	42.71M	44.87M	57.07M
ECS Total Common Shares Outstanding	37.64M	39.13M	42.71M	44.05M	56.31M
Book Value / Share	4.01	4.17	3.69	0.77	0.6
Tangible Book Value	66.86M	78.02M	75.54M	-56.43M	-54.48M
Tangible Book Value Per Share	1.78	1.99	1.77	-1.28	-0.97
Total Debt	186M	198M	329M	354M	328M
Net Debt	67.55M	149M	190M	321M	300M
Debt Equivalent Oper. Leases	3.13M	392K	664K	2.58M	1.58M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	8.34M	-	32.44M	38.89M	48.78M
Inventories - Work In Process, Total	-	-	2.92M	5.03M	1.7M
Inventories - Finished Goods, Total	2.97M	-	25K	5K	316K
Land - (BS)	71.62M	2.73M	3.32M	4.48M	4.69M
Machinery, Total	18.4M	25.69M	34.06M	44.42M	50.39M
Full Time Employees	129	172	229	248	229
Order Backlog	-	486M	-	-	-

Fiscal Period: December	2018	2019	2020	2021	2022
Net Income	-12.36M	-26.56M	-92.09M	-117M	-59.62M
Depreciation & Amortization - CF	3.62M	5.3M	5.7M	7.78M	8.8M
Amortization of Goodwill and Intangible Assets - (CF)	-771K	131K	3.55M	1.57M	1.8M
Depreciation & Amortization, Total	2.85M	5.43M	9.24M	9.35M	10.59M
Amortization of Deferred Charges, Total - (CF)	-	344K	524K	1.08M	1.35M
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	1.18M	4.9M	7.27M	1.06M	1.98M
Provision and Write-off of Bad Debts	-	-	-	-	77K
Net Cash From Discontinued Operations	-18.48M	-	-	-	-
Other Operating Activities, Total	47.08M	22.05M	6.48M	24.85M	19.93M
Change In Accounts Receivable	10.11M	-58.96M	7.13M	16.67M	-42.48M
Change In Inventories	-7.6M	-5.28M	-19.1M	-8.47M	-6.87M
Change In Accounts Payable	-9.05M	11.59M	521K	-2.05M	18.23M
Change in Unearned Revenues	-10.18M	-	-	-	-
Change In Income Taxes	-	-334K	-	-	-
Change in Other Net Operating Assets	-	-	-	-	-
Cash from Operations	3.54M	-46.83M	-80.02M	-74.39M	-56.82M
Capital Expenditure	-10.01M	-11.12M	-10.64M	-11.48M	-6.36M
Sale of Property, Plant, and Equipment	19.35M	-	23K	-	169K
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-90K	-4.34M	-5.58M	-9.7M	-19.3M
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Other Investing Activities, Total	-3.69M	-5M	-	-33.5M	-1K
Cash from Investing	5.56M	-20.46M	-16.21M	-54.68M	-25.49M
Long-Term Debt Issued, Total	3.28M	15.22M	164M	83.64M	76.82M
Total Debt Issued	3.28M	15.22M	164M	83.64M	76.82M
Long-Term Debt Repaid, Total	-1.36M	-14.02M	-40.83M	-57.84M	-39.13M
Total Debt Repaid	-1.36M	-14.02M	-40.83M	-57.84M	-39.13M
Issuance of Common Stock	77.5M	170K	65.73M	9.21M	50.04M
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-5.76M	-3.32M	-3.5M	-11.77M	-9.86M
Cash from Financing	73.65M	-1.95M	185M	23.24M	77.87M
Foreign Exchange Rate Adjustments	-	-	-	21K	-147K
Miscellaneous Cash Flow Adjustments	-	-	-1K	-	-
Net Change in Cash	82.76M	-69.23M	88.95M	-106M	-4.59M
Supplemental Items
Cash Interest Paid	3.46M	3.32M	3.5M	11.76M	9.86M
Cash Income Tax Paid (Refund)	-	-359K	-	-	322K
Levered Free Cash Flow	-17.4M	3.34M	-112M	-40.75M	-54.4M
Unlevered Free Cash Flow	-14.05M	5.41M	-109M	-33.4M	-43.77M
Change In Net Working Capital	16.85M	6.09M	57.87M	-31.22M	15.64M
Net Debt Issued / Repaid	1.92M	1.2M	123M	25.8M	37.69M

Fiscal Period: December	2018	2019	2020	2021	2022
Profitability
Return on Assets	2.95	4.3	-11.37	-11.64	-3.8
Return on Total Capital	3.26	4.66	-12.33	-12.57	-4.38
Return On Equity %	-23.22	-17.33	-57.37	-122.01	-176.58
Return on Common Equity	-23.22	-17.33	-57.37	-122.01	-176.58
Margin Analysis
Gross Profit Margin %	97.29	97.42	61.72	30.63	70.71
SG&A Margin	18.93	16.9	192.33	63.46	25.04
EBITDA Margin %	29.44	29.5	-863.08	-366.11	-30.78
EBITA Margin %	23.18	27.12	-887.4	-380.72	-36.49
EBIT Margin %	24.51	26.99	-926.67	-387.67	-39.17
Income From Continuing Operations Margin %	-47.7	-28.2	-1.02K	-515.59	-88.99
Net Income Margin %	-21.36	-27.52	-1.02K	-515.59	-88.99
Net Avail. For Common Margin %	-47.7	-28.2	-1.02K	-515.59	-88.99
Normalized Net Income Margin	9.78	12.7	-608.26	-271.64	-39.46
Levered Free Cash Flow Margin	-30.07	3.46	-1.24K	-179.77	-81.2
Unlevered Free Cash Flow Margin	-24.27	5.61	-1.21K	-147.33	-65.34
Asset Turnover
Asset Turnover	0.19	0.25	0.02	0.05	0.16
Fixed Assets Turnover	0.8	1.08	0.09	0.22	0.63
Receivables Turnover (Average Receivables)	2.57	6.99	0.23	0.61	1.86
Inventory Turnover (Average Inventory)	0.21	0.18	0.13	0.4	0.42
Short Term Liquidity
Current Ratio	4.26	1.91	3.37	1.04	1.12
Quick Ratio	3.91	1.55	2.8	0.54	0.69
Operating Cash Flow to Current Liabilities	0.1	-0.98	-1.13	-0.78	-0.44
Days Sales Outstanding (Average Receivables)	141.81	52.24	1.6K	595.14	196.14
Days Outstanding Inventory (Average Inventory)	1.75K	1.99K	2.73K	919.63	875.75
Average Days Payable Outstanding